Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07459205) titled 'Clinical Application of 68Ga-1A12 PET in Fibrosis-related Diseases' on March 4.
Study Type: Observational
Primary Sponsor: Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Condition:
Pulmonary Fibrosis
Recruitment Status: Not recruiting
Date of First Enrollment: March 1, 2026
Target Sample Size: 50
Countries of Recruitment:
China
To know more, visit https://clinicaltrials.gov/study/NCT07459205
Disclaimer: Curated by HT Syndication....